English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/188962
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Impact of foods and dietary supplements containing hydroxycinnamic acids on cardiometabolic biomarkers: a systematic review to explore inter-individual variability

AuthorsMartini, Daniela; Chiavaroli, Laura; González-Sarrías, Antonio ; Bresciani, Letizia; Palma-Duran, Susana A.; Dall’Asta, Margherita; Deligiannidou, Georgia-Eirini; Massaro, Marika; Scoditti, Egeria; Combet, Emilie; Maksimova, Viktorija; Urpi-Sarda, Mireia; Kontogiorgis, Christos A.; Andrés-Lacueva, Cristina; Gibney, Eileen R.; Rio, Daniele del; Morand, Christine; Garcia-Aloy, Mar; Rodriguez-Mateos, Ana; Mena, Pedro
Caffeoylquinic acids
Hydroxycinnamic acids
Dietary supplements
Interindividual variability
Cardiometabolic health
Issue Date5-Aug-2019
PublisherMultidisciplinary Digital Publishing Institute
CitationNutrients 11(8): 1805 (2019)
AbstractPlant-based diets rich in bioactive compounds such as polyphenols have been shown to positively modulate the risk of cardiometabolic (CM) diseases. The inter-individual variability in the response to these bioactives may affect the findings. This systematic review aimed to summarize findings from existing randomized clinical trials (RCTs) evaluating the effect of hydroxycinnamic acids (HCAs) on markers of CM health in humans. Literature searches were performed in PubMed and the Web of Science. RCTs on acute and chronic supplementation of HCA-rich foods/extracts on CM biomarkers were included. Forty-four RCTs (21 acute and 23 chronic) met inclusion criteria. Comparisons were made between RCTs, including assessments based on population health status. Of the 44 RCTs, only seven performed analyses on a factor exploring inter-individual response to HCA consumption. Results demonstrated that health status is a potentially important effect modifier as RCTs with higher baseline cholesterol, blood pressure and glycaemia demonstrated greater overall effectiveness, which was also found in studies where specific subgroup analyses were performed. Thus, the effect of HCAs on CM risk factors may be greater in individuals at higher CM risk, although future studies in these populations are needed, including those on other potential determinants of inter-individual variability. PROSPERO, registration number CRD42016050790.
Publisher version (URL)https://doi.org/10.3390/nu11081805
Appears in Collections:(CEBAS) Artículos
Files in This Item:
File Description SizeFormat 
impact_foods_dietary_supplements_containing_hydroxycinnamic_acids.pdf519,77 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.